Officer received an award of 8,080 STE derivative securities | OQRO Insider tradesWhy it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Jun 2, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Jun 4, 2026
OfficerGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001628280-26-040841
- Filed / recorded
Jun 4, 2026, 8:33 PM UTCAdded to OQROOct 2, 2026, 12:26 PM UTC Data qualityVerified: identifiers matched exactly Reporting personJulia Madsen Officer titleSr. VP and GM, Life Sciences SecurityEmployee Stock Option (right to buy) TableDerivative (Table II) Transaction dateJun 2, 2026 Acquired / disposedAcquired (A) Footnotes from the filing
- This option becomes exercisable as follows: 2,020 on June 2, 2027, 2,020 on June 2, 2028, 2,020 on June 4, 2029 and 2,020 on June 3, 2030.
Around the same time
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
Derivative exercise or conversion — not an open-market buy.